DoD Prostate Cancer Exceptional Responders Award

Funding Opportunity Number: W81XWH-15-PCRP-ERA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Sep 24, 2015Award Ceiling: $0Expected Number of Awards: 1Creation Date: May 20, 2015Funding Opportunity Description: The PCRP Exceptional Responders Award (ERA) mechanism is being offered for the first time in FY15. This award supports a research effort conducted by leading prostate cancer researchers that specifically focuses on identifying and understanding predictors of disease outcomes in exceptional responders to prostate cancer therapies. Research projects proposed under the ERA can be either discovery or target-driven but must include an in-depth examination of outlier responses to prostate cancer therapy that will lead to significant improvements to the clinical management of prostate cancer. The research project should address overarching issues that have broad implications for the disease and risk management, such as risk factors at the individual level and systems level, treatment, toxicity, and dormancy. The research project should not focus merely on the study of specific molecular pathway...
Source: Grants.gov - Category: Research Tags: Science and Technology and other Research and Development Source Type: funding